The DNA of Escherichia coli is largely confined to one or a few compact bodies known as nucleoids. The nucleoids occupy only a small fraction of the nominal cellular volume. The factors causing their compaction have been difficult to characterize, in part because of the lack of suitable experimental systems. We here use lysed cell preparations to examine the effects of release of cytoplasm on nucleoid compaction. Lysis was accomplished with retention of sufficient residual cell wall material to form a rod-shaped boundary that continued to enclose the DNA. DNA fluorescence and phase contrast microscopy were compared in order to localize the DNA inside this boundary. Lysis of exponential phase cells of E. coli allowed expansion of the DNA to fill the volume within the boundary. This expansion supports our earlier suggestion of the powerful DNA compaction associated with macromolecular crowding from the bacterial cytoplasm. In contrast, lysis of cells that had been preexposed to chloramphenicol or nalidixic acid to generate the characteristic DNA structures associated with those drugs was not accompanied by an expansion of the DNA to fill the boundaries of those cells. The restricted expansion of the DNA upon lysis of chloramphenicol- or nalidixic acid-treated cells indicated the presence of alternative, more stable DNA structures; in accord with this interpretation, dilatancy assays of spermidine nucleoids from nalidixic acid-treated cells showed increased resistance to unfolding in urea solutions, as had been found earlier for nucleoids from chloramphenicol-treated cells.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Intramural Research (Z01)
Project #
1Z01DK036120-03
Application #
6432122
Study Section
(LMB)
Project Start
Project End
Budget Start
Budget End
Support Year
3
Fiscal Year
2000
Total Cost
Indirect Cost
Name
U.S. National Inst Diabetes/Digst/Kidney
Department
Type
DUNS #
City
State
Country
United States
Zip Code
Gu, Fangyi; Derkach, Andriy; Freedman, Neal D et al. (2016) Cigarette smoking behaviour and blood metabolomics. Int J Epidemiol 45:1421-1432
Sung, Hyuna; Yang, Howard H; Hu, Nan et al. (2016) Functional annotation of high-quality SNP biomarkers of gastric cancer susceptibility: the Yin Yang of PSCA rs2294008. Gut 65:361-4
Ji, Xuemei; Gui, Jiang; Han, Younghun et al. (2015) The role of haplotype in 15q25.1 locus in lung cancer risk: results of scanning chromosome 15. Carcinogenesis 36:1275-83
Faupel-Badger, Jessica M; Duggan, Maire A; Sherman, Mark E et al. (2014) Prolactin receptor expression and breast cancer: relationships with tumor characteristics among pre- and post-menopausal women in a population-based case-control study from Poland. Horm Cancer 5:42-50
De Matteis, Sara; Consonni, Dario; Pesatori, Angela C et al. (2013) Are women who smoke at higher risk for lung cancer than men who smoke? Am J Epidemiol 177:601-12
Sahasrabuddhe, Vikrant V; Castle, Philip E; Follansbee, Stephen et al. (2013) Human papillomavirus genotype attribution and estimation of preventable fraction of anal intraepithelial neoplasia cases among HIV-infected men who have sex with men. J Infect Dis 207:392-401
Wentzensen, Nicolas; Follansbee, Stephen; Borgonovo, Sylvia et al. (2012) Human papillomavirus genotyping, human papillomavirus mRNA expression, and p16/Ki-67 cytology to detect anal cancer precursors in HIV-infected MSM. AIDS 26:2185-92
Shakeri, Ramin; Kamangar, Farin; Nasrollahzadeh, Dariush et al. (2012) Is opium a real risk factor for esophageal cancer or just a methodological artifact? Hospital and neighborhood controls in case-control studies. PLoS One 7:e32711
Shiels, Meredith S; Engels, Eric A (2012) Increased risk of histologically defined cancer subtypes in human immunodeficiency virus-infected individuals: clues for possible immunosuppression-related or infectious etiology. Cancer 118:4869-76
Weischer, Maren; Nordestgaard, Børge G; Pharoah, Paul et al. (2012) CHEK2*1100delC heterozygosity in women with breast cancer associated with early death, breast cancer-specific death, and increased risk of a second breast cancer. J Clin Oncol 30:4308-16

Showing the most recent 10 out of 38 publications